Abbott Laboratories Offers Long-Term Upside Despite Recent Stumbles [Seeking Alpha]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Seeking Alpha
Core Devices and Diagnostics segments continue to deliver high single-digit sales growth and double-digit EPS growth, supporting the investment thesis. Nutrition remains a key risk, but management expects a turnaround in the second half; Exact Sciences acquisition could add a new high-growth vertical. Valuation offers upside if execution improves, with $130–$140 achievable if Nutrition rebounds and Exact Sciences integration succeeds. jetcityimage/iStock Editorial via Getty Images Abbott Laboratories ( ABT ) heads into the next stretch with a pretty clear plan: still mostly positive on the long-term, but recent stock drops and some messy execution make things a bit trickier. I said This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Workflow Services Supports Walgreens National Colorectal Cancer Initiative to Close Screening Gaps; Leverages Cologuard® Tests to Expand Reach [Yahoo! Finance]Yahoo! Finance
- Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year [Yahoo! Finance]Yahoo! Finance
- Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive YearBusiness Wire
- Exact Sciences (EXAS) Merger with Abbott Moving Forward After Shareholder Approval [Yahoo! Finance]Yahoo! Finance
- Exact Sciences Stockholders Approve Acquisition by AbbottBusiness Wire
EXAS
Earnings
- 2/13/26 - Miss
EXAS
Sec Filings
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- 2/27/26 - Form 4
- EXAS's page on the SEC website